References
- Chua TC, Morris DL. Therapeutic potential of surgery for metastatic colorectal cancer. Scand J Gastroenterol 2012;47(3):258–68.
- Gustavsson B. Simultaneous surgery for primary colorectal cancer and metastatic lesions? Scand J Gastroenterol 2012;47(3):269–76.
- Chua TC, Petz JOW, Morris DL. Surgery for colorectal peritoneal carcinomatosis. Scand J Gastroenterol 2012;47(3):277–85.
- Brouquet A, Nordlinger B. Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases. Scand J Gastroenterol 2012;47(3):286–95.
- Glimelius B, Cavalli-Björkman N. Metastatic colorectal cancer: Current treatment and future options for improved survival. Scand J Gastroenterol 2012;47(3):296–314.
- Ellebaek E, Andersen MH, Svane IM, Thor Straten P. Immunotherapy for metastatic colorectal cancer present status and new options. Scand J Gastroenterol 2012;47(3):315–24.
- Benhaim L, LaBonte MJ, Lenz H-J. Pharmacogenomics and metastatic colorectal cancer: Current knowledge and perspectives. Scand J Gastroenterol 2012;47(3):325–39.
- Jensen NF, Smidt DH, Nygård SB, Rømer MU, Nielsen KV, Brünner N. Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer. Scand J Gastroenterol 2012;47(3):340–55.
- Shi Q, Mandrakar SJ, Sargent DJ. Predictive biomarkers in colorectal cancer: usage, validation and design in clinical trials. Scand J Gastroenterol 2012;47(3):356–62.
- Nielsen HJ, Brünner N. Directions for further improvements of treatment of metastatic colorectal cancer. Scand J Gastroenterol 2012;47(3):363–4.